Saudi Arabia

 

Aster DM set to sell GCC business

Listed hospital group Aster DM’s share price has rocketed in anticipation as the group’s long-awaited sale in the Gulf looms closer.

Blackstone likely buyer of KIMS Health

US private equity firm Blackstone has emerged as the likely buyer in the sale process of KIMS Health, an Indian hospital group which also has multiple hospitals and clinics in the Middle East.

FREE BLOG Emerging market providers make up half the Top 50

Half the top 50 listed health care service groups globally by market cap are now headquartered in emerging markets. What does that tell us about the sector internationally?  We publish the top 50 with detailed analysis in Deals and Insights.

Saudi crackdown will shut businesses as new path paved for investors

The Saudi Arabian government is overhauling the regulatory regime governing its health care sector to make way for the huge amounts of private investment needed to deliver ambitious growth targets. As well as simplifying laws governing private ownership and foreign investment, it is increasing auditing checks on providers - and closing hundreds of sites that don’t meet health standards.

HBI 2023: The outpatient differential

For years there has been a trend towards using outpatient services wherever possible - to improve patient outcomes, to better use an increasingly scarce workforce, and to increase cost efficiency. On the “Outpatient differential” panel at HBI 2023, how this push looks across the world was a key topic for discussion.

HBI 2023: Saudi opportunity “best you could get”

The scepticism which used to exist about whether the Saudi government would follow through on its ambitious moonshot projects appears to be dissipating. Investors are now increasingly confident - and enthusiastic - about the opportunities presented by one of the most rapidly developing economies in the world. This was the overwhelming message from speakers on the ‘Investing in MENA’ panel at HBI 2023.

Fighting back against brain drain

Western Europe is becoming increasingly dependent on importing talent to address its workforce crisis, but there are signs of resistance to the brain drain. With Nigeria looking to introduce a mandatory domestic five-year service for all doctors, HBI speaks to a global workforce expert to see if this kind of pushback could have any lasting impact.

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Find Us